Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests

Understanding differences in Alzheimer’s disease biomarkers before the pathology becomes evident can contribute to an improved understanding of disease pathogenesis and treatment. A decrease in amyloid-β (Aβ)(42) in cerebrospinal fluid (CSF) is suggested to be a biomarker for Aβ deposition in brain....

Descripción completa

Detalles Bibliográficos
Autores principales: Borghys, Herman, Van Broeck, Bianca, Dhuyvetter, Deborah, Jacobs, Tom, de Waepenaert, Katja, Erkens, Tim, Brooks, Melissa, Thevarkunnel, Sandy, Araujo, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271428/
https://www.ncbi.nlm.nih.gov/pubmed/28035921
http://dx.doi.org/10.3233/JAD-160434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271428/
https://www.ncbi.nlm.nih.gov/pubmed/28035921
http://dx.doi.org/10.3233/JAD-160434

Ejemplares similares